Natixis North America美国利率策略主管John Briggs指出，美联储将更加关注失业率本身，而非就业数据 中的短期噪音，"在我看来，这对美债利率来说略偏空"。 回顾全年表现，美国国债在去年累计上涨逾6%，创下自2020年以来的最佳年度表现，主要受益于市场 对就业市场降温的预期。最新数据公布后，交易员目前将下一次降息时间定价在6月，即美联储主席鲍 威尔任期结束后的一个月，随后可能在第四季度再度放松政策。 策略师认为，12月就业结构的细分数据仍显示劳动力市场存在潜在疲软迹象，这在一定程度上抵消了失 业率下降对债市的利空影响。 智通财经APP获悉，在美国12月失业率降幅超出市场预期后，美国国债周五全线下跌，交易员几乎完全 抹去了对美联储在本月晚些时候降息的押注。随着国债价格回落，各期限美债收益率普遍上行，涨幅最 高约3个基点。 尽管短期内降息预期明显降温，债券交易员仍维持对2026年整体将有两次降息的判断，首次降息时间被 认为可能出现在年中前后。 PGIM Fixed Income首席投资策略师Robert Tipp在接受采访时表示，这一数据并未改变美联储逐步降息 的大方向。"这仍然符合美联储 ...

美国纽约商品交易所黄金期货价格22日在电子盘交易中突破每盎司4500美元，白银期货价格突破每盎司69美元。 在地缘政治紧张局势加剧背景下，避险需求涌现，拉动黄金、白银价格强劲上涨，再创历史新高。交投最活跃的2026年2月黄金期价盘中交易价格一度达 每盎司4520.5美元。3月白银期价交易价格一度达每盎司69.755美元。 摩根大通在其2026年黄金市场展望报告中认为，由于驱动因素依然强劲，黄金市场在2026年或将延续上涨势头。与此同时，一些市场分析人士预计2026年 白银需求也将继续增长。 这是10月23日在科威特首都科威特城一家金店内拍摄的黄金饰品。新华社发（阿萨德摄） 2025年以来，关税政策带来的不确定性、黄金交易所交易基金（ETF）和各国央行对黄金的强劲需求推动金价不断创下历史新高。 ...

新华社纽约12月22日电（记者徐静）美国纽约商品交易所黄金期货价格22日在电子盘交易中突破每盎司 4500美元，白银期货价格突破每盎司69美元。 2025年以来，关税政策带来的不确定性、黄金交易所交易基金（ETF）和各国央行对黄金的强劲需求推 动金价不断创下历史新高。 摩根大通在其2026年黄金市场展望报告中认为，由于驱动因素依然强劲，黄金市场在2026年或将延续上 涨势头。与此同时，一些市场分析人士预计2026年白银需求也将继续增长。 【纠错】 【责任编辑:谷玥】 在地缘政治紧张局势加剧背景下，避险需求涌现，拉动黄金、白银价格强劲上涨，再创历史新高。交投 最活跃的2026年2月黄金期价盘中交易价格一度达每盎司4520.5美元。3月白银期价交易价格一度达每盎 司69.755美元。 ...

答:understance 品牌去年收入是约 6000 万人民币，毛利率约57%，主要市场是加拿大和美国。过去一年 以来关税政策经常变化，未来中美、美加关税政策不确定性因素无法排除，公司今年12月决定终止运营 understance 品牌，并逐步清理存货。 格隆汇12月12日丨汇洁股份(002763.SZ)在投资者关系中表示，有被问到:understance 运营情况和后续规 划？ ...

Core Insights - Wall Street macro traders are set to achieve their best performance since 2009, driven by clients betting on changes in global central bank interest rate policies [1] Group 1: Revenue Projections - Goldman Sachs, JPMorgan, and Citigroup are expected to generate $165 billion in revenue from fixed income, credit, and commodity trading this year, representing a 10% increase compared to 2024 [1] - G-10 interest rate business revenue is projected to reach $40 billion, marking a five-year high [1] Group 2: Market Influences - Factors such as global central bank interest rate adjustments, uncertainty in tariff policies, concerns over expanding fiscal deficits, and steepening yield curves are contributing to the increase in revenue for rate traders [1] - A similar revenue surge is anticipated in 2026, with industry revenue expected to reach $162 billion [1]

Core Viewpoint - The company, Qizheng Tibetan Medicine, is experiencing stable stock performance despite external economic uncertainties, with minimal impact on production costs and profits due to its limited exposure to U.S. imports [1]. Company Performance - As of October 15, 2025, Qizheng Tibetan Medicine's stock closed at 26.73 yuan, reflecting a 0.3% increase with a turnover rate of 0.8% and a trading volume of 45,900 shares, resulting in a transaction value of 1.22 billion yuan [1]. - The company reported that foreign business revenue accounted for only 0.05% of total revenue in the first half of 2025, indicating that changes in U.S. policies will have a negligible effect on overall income [1]. Market Sentiment - On October 15, 2025, the net inflow of main funds into the stock was 7.38 million yuan, while speculative funds also saw a net inflow of 7.24 million yuan, suggesting a positive market sentiment towards the stock [1]. - Retail investors, however, showed a net outflow of 14.63 million yuan, indicating a divergence in investment behavior among different investor classes [1].

Core Viewpoint - Zhongyuan Home Furnishing (603709.SH) has announced that its products are primarily export-oriented, and the current U.S. tariff policy remains highly uncertain, prompting the company to continuously monitor and assess potential impacts while adopting flexible strategies to respond accordingly [2] Company Summary - Zhongyuan Home Furnishing's main focus is on export products, which makes it sensitive to changes in international trade policies, particularly U.S. tariffs [2] - The company is committed to staying vigilant regarding the evolving tariff landscape and is prepared to implement relevant strategies to mitigate risks [2]

Group 1 - The U.S. labor market is showing signs of weakness, with predictions of modest job growth and an increase in the unemployment rate to 4.3% for August, which may lead to a definitive decision on interest rate cuts by the Federal Reserve [1] - The upcoming employment report is significant as it follows news that the number of unemployed in July exceeded job vacancies for the first time since the pandemic [1] - Economic growth in employment is being hindered by high tariffs and immigration policies under the Trump administration, which have led to a reduced labor supply [1][2] Group 2 - Economists expect non-farm payrolls to increase by 75,000 in August, a slight rise from 73,000 in July, but this growth is seen as realistic given the reduced labor supply [1] - The average monthly job creation in the second quarter was only 35,000, significantly lower than the 123,000 in the same period of 2024 [2] - A potential downward revision of employment levels by up to 800,000 is anticipated, based on quarterly employment and wage census data [3] Group 3 - The labor market is experiencing a low turnover rate, with job growth primarily driven by the net creation of new companies, which is the most sensitive area for data adjustments [2] - The manufacturing sector may face job losses due to a strike involving 3,200 Boeing workers, compounded by existing pressures from tariffs [5] - There are indications that labor demand weakened further in August, with economists warning that the risks of layoffs may have been underestimated by the market and Federal Reserve officials [5]

Group 1 - The U.S. stock market experienced a collective decline on September 2, with the Dow Jones Industrial Average falling by 249.07 points to 45295.81, a decrease of 0.55% [2] - Major technology stocks weakened, with Nvidia dropping 1.95% and breaking below its 50-day moving average, indicating a potential loss of short-term upward momentum [2] - Kraft Heinz announced a split plan, resulting in a significant drop of 7% in its stock price [3] Group 2 - The ISM manufacturing index for August recorded at 48.7, marking the sixth consecutive month in contraction territory, with output indicators falling to 47.8 [4] - PepsiCo's stock rose by 1.1% after Elliott Management disclosed a $4 billion stake and proposed active shareholder actions, suggesting potential governance and capital allocation improvements [4] - Kraft Heinz's stock decline followed its announcement to split into two companies focusing on grocery and sauce products [4] Group 3 - Oil prices continued to rebound, with WTI crude futures rising by 2.47% to $65.59 per barrel, and Brent crude futures increasing by 1.45% to $69.14 per barrel [4] - Gold futures reached a new historical high, closing up 2.16% at $3592.2 per ounce, driven by geopolitical and policy uncertainties increasing demand for safe-haven assets [4]

Core Viewpoint - Changmao Biological (00954) reported a decline in revenue and an increase in losses for the first half of 2025, primarily due to external geopolitical factors and changes in product demand and pricing [1] Financial Performance - Revenue for the first half of 2025 was approximately 272 million yuan, representing a year-on-year decrease of 13.23% [1] - The loss attributable to shareholders was 25.79 million yuan, an increase of 37.28% compared to the previous year [1] - Earnings per share showed a loss of 0.049 yuan [1] Contributing Factors - The decline in performance was influenced by external factors such as geopolitical conflicts and uncertainties in tariff policies [1] - Demand for downstream products of phthalic anhydride was below expectations, and the release of new production capacity altered the supply-demand balance, indirectly affecting product prices and profitability [1] - The increase in interest expenses in the consolidated income statement was due to a reduction in the amount of capitalized interest on qualifying assets [1]